These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 6822328)
1. Immunoglobulin M antibody against hepatitis B core antigen for the diagnosis of fulminant type B hepatitis. Shimizu M; Ohyama M; Takahashi Y; Udo K; Kojima M; Kametani M; Tsuda F; Takai E; Miyakawa Y; Mayumi M Gastroenterology; 1983 Mar; 84(3):604-10. PubMed ID: 6822328 [TBL] [Abstract][Full Text] [Related]
2. Clinical and prognostic values of anti-hepatitis B core immunoglobulin M detection in asymptomatic hepatitis B surface antigen carriers. Ali HY; Faransawy ZE; Al-Megthab NA Saudi Med J; 2002 Jul; 23(7):777-81. PubMed ID: 12174223 [TBL] [Abstract][Full Text] [Related]
3. Immunoglobulin M hepatitis B core antibody: to titer or not to titer? to use or not to use? Gitnick G Gastroenterology; 1983 Mar; 84(3):653-5. PubMed ID: 6822334 [No Abstract] [Full Text] [Related]
4. [Incidence of antibody against hepatitis B core antigen (anti-HBc) in chronic diffuse liver diseases]. Dávid K; Halmy L Orv Hetil; 1983 Apr; 124(15):879-84. PubMed ID: 6856288 [No Abstract] [Full Text] [Related]
5. Low molecular weight (7s) immunoglobulin M antibody against hepatitis B core antigen in the serum for differentiating acute from persistent hepatitis B virus infection. Tsuda F; Naito S; Takai E; Akahane Y; Furuta S; Miyakawa Y; Mayumi M Gastroenterology; 1984 Jul; 87(1):159-64. PubMed ID: 6724259 [TBL] [Abstract][Full Text] [Related]
6. Core antigen-specific immunoglobulin G bound to the liver cell membrane in chronic hepatitis B. Trevisan A; Realdi G; Alberti A; Ongaro G; Pornaro E; Meliconi R Gastroenterology; 1982 Feb; 82(2):218-22. PubMed ID: 7033035 [TBL] [Abstract][Full Text] [Related]
7. Fulminant viral hepatitis (type B) in the late stage of pregnancy showing an unusual pattern of serum antigen and antibody: report of a case. Nakamura F; Sasaki H; Ueda M; Yamanoue M; Kajihara H Hiroshima J Med Sci; 1988 Mar; 37(1):45-9. PubMed ID: 3410735 [No Abstract] [Full Text] [Related]
8. Radioimmunoassay detection of IgM antibodies to the hepatitis B core antigen in HBsAg liver disease. Lavarini C; Crivelli O; Smedile A; Farci P; Marinucci G; Muglia M; Rizzetto M Boll Ist Sieroter Milan; 1982; 61(3):210-7. PubMed ID: 6985422 [TBL] [Abstract][Full Text] [Related]
9. Delta hepatitis in inapparent carriers of hepatitis B surface antigen. A disease simulating acute hepatitis B progressive to chronicity. Farci P; Smedile A; Lavarini C; Piantino P; Crivelli O; Caporaso N; Toti M; Bonino F; Rizzetto M Gastroenterology; 1983 Sep; 85(3):669-73. PubMed ID: 6873613 [TBL] [Abstract][Full Text] [Related]
10. Fulminant B viral hepatitis: role of delta agent. Govindarajan S; Chin KP; Redeker AG; Peters RL Gastroenterology; 1984 Jun; 86(6):1417-20. PubMed ID: 6714570 [TBL] [Abstract][Full Text] [Related]
11. [Detection of a class IgM antibody against the core antigen of the hepatitis B virus in patients with chronic infection]. Quiroga JA; Bartolomé J; Carreño V; Mora I; Porres JC; Gutiez J; Hernández Guío C Rev Clin Esp; 1987 Nov; 181(7):351-5. PubMed ID: 3423340 [No Abstract] [Full Text] [Related]
12. Hepatitis B markers among dialysis patients without hepatitis B surface antigen or antibody. Kelly TJ; Sanchez TV; Patterson MJ; Mayor GH Proc Clin Dial Transplant Forum; 1980; 10():165-8. PubMed ID: 7346842 [No Abstract] [Full Text] [Related]
13. An outbreak of fulminant hepatitis B in immunocompromised hemodialysis patients. Igaki N; Nakaji M; Moriguchi R; Akiyama H; Tamada F; Oimomi M; Goto T J Gastroenterol; 2003; 38(10):968-76. PubMed ID: 14614604 [TBL] [Abstract][Full Text] [Related]
14. A revised method for estimating hepatitis B virus transfusion residual risk based on antibody to hepatitis B core antigen incident cases. Laperche S; Maniez M; Barlet V; El Ghouzzi MH; Le Vacon F; Levayer T; Lunel F; Morel P; Mouillot L; Piquet Y; Pillonel J; Transfusion; 2008 Nov; 48(11):2308-14. PubMed ID: 18673347 [TBL] [Abstract][Full Text] [Related]
15. Significance of antibody to hepatitis B core antigen in a hemodialysis unit. Wasnich RD; Puapongsakorn R; Seto DS West J Med; 1980 Apr; 132(4):279-82. PubMed ID: 7385831 [TBL] [Abstract][Full Text] [Related]
16. A multiple centre clinical study of third-generation enzyme immunoassays for hepatitis B surface antigen and hepatitis B core IgM class antibody. Jakob R Eur J Clin Chem Clin Biochem; 1993 Apr; 31(4):259-66. PubMed ID: 8318575 [TBL] [Abstract][Full Text] [Related]
17. The significance of IgM antibodies to hepatitis B core antigen in hepatitis B carriers and hepatitis B-associated chronic liver disease. Feinman SV; Overby LR; Berris B; Chau K; Schable CA; Maynard JE Hepatology; 1982; 2(6):795-9. PubMed ID: 7141390 [No Abstract] [Full Text] [Related]
18. High titre of antibody to hepatitis B core antigen detected by immune adherence haemagglutination in HBsAg-positive acute hepatitis. Ikegami F; Takasu S; Jo K; Miyakawa Y; Tsuda F; Mayumi M Hepatogastroenterology; 1982 Aug; 29(4):142-3. PubMed ID: 7129336 [TBL] [Abstract][Full Text] [Related]
19. Trial of lamivudine in hepatitis B surface antigen carriers with persistent hepatitis B core IgM antibody. Ali HY Saudi Med J; 2003 Sep; 24(9):996-9. PubMed ID: 12973486 [TBL] [Abstract][Full Text] [Related]
20. Poor response to 18-month lamivudine monotherapy in chronic hepatitis B patients with IgM anti-HBc and acute exacerbation. Chen JJ; Lin CY; Sheu MJ; Kuo HT; Sun CS; Tang LY; Wang SL; Tsai SL Aliment Pharmacol Ther; 2006 Jan; 23(1):85-90. PubMed ID: 16393284 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]